Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2007-6-18
pubmed:abstractText
Dexmedetomidine, an alpha(2)-adrenoceptor agonist, has been approved for clinical use, although the mechanism of dexmedetomidine action has not been fully elucidated. Several studies have shown that G protein-coupled receptors (GPCRs) are recognized as targets for anesthetics and analgesics. Therefore, it is of interest to determine whether dexmedetomidine affects the function of GPCRs other than the alpha(2)-adrenoceptor. We examined the effects of dexmedetomidine on M(1), M(3), 5-HT(2C), substance P, and orexin 1 receptors in Xenopus oocytes expressing individual receptors. In addition, we investigated the effects of dexmedetomidine on muscarinic receptor-mediated changes in [Ca(2+)](i) in the dorsal root ganglia (DRG) of 3-week-old Wister rats. Dexmedetomidine did not affect the 5-HT(2C)-, or substance P-induced Cl(-) currents and had little inhibition on the orexin A-induced current in oocytes expressing the respective receptors. The compound also had little effect on the acetylcholine (ACh, 1 microM)-induced Ca(2+)-activated Cl(-) currents in Xenopus oocytes expressing M(1) receptors. In contrast, dexmedetomidine inhibited the ACh-induced currents in Xenopus oocytes expressing M(3) receptors; 1 nM, 10 nM, 100 nM, and 1 microM dexmedetomidine reduced the current to 66.5 +/- 4.8, 51.3 +/- 12, 34.6 +/- 11, and 26.8 +/- 6.4% of the control value, respectively (EC(50) = 3.5 +/- 0.7 nM). Dexmedetomidine reduced the ACh-induced Cl(-) currents after treatment with the selective protein kinase C inhibitor GF109203X. Moreover, the compound inhibited the muscarinic receptor-mediated increases in [Ca(2+)](i) in cultured DRG cells in a concentration-dependent manner. Dexmedetomidine inhibits the function of M(3) receptors, in addition to its agonistic effects on alpha(2)-adrenoceptors, which provides further insight into the pharmacological properties of dexmedetomidine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine, http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Non-Narcotic, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Chloride Channels, http://linkedlifedata.com/resource/pubmed/chemical/Dexmedetomidine, http://linkedlifedata.com/resource/pubmed/chemical/Hypnotics and Sedatives, http://linkedlifedata.com/resource/pubmed/chemical/Muscarine, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Muscarinic M1, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Muscarinic M3, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Serotonin, 5-HT2C, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, G-Protein-Coupled, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neurokinin-1, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neuropeptide, http://linkedlifedata.com/resource/pubmed/chemical/orexin receptors
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0028-1298
pubmed:author
pubmed:issnType
Print
pubmed:volume
375
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
293-301
pubmed:meshHeading
pubmed-meshheading:17563882-Acetylcholine, pubmed-meshheading:17563882-Adrenergic alpha-Agonists, pubmed-meshheading:17563882-Analgesics, Non-Narcotic, pubmed-meshheading:17563882-Animals, pubmed-meshheading:17563882-Calcium, pubmed-meshheading:17563882-Cells, Cultured, pubmed-meshheading:17563882-Chloride Channels, pubmed-meshheading:17563882-Dexmedetomidine, pubmed-meshheading:17563882-Female, pubmed-meshheading:17563882-Ganglia, Spinal, pubmed-meshheading:17563882-Hypnotics and Sedatives, pubmed-meshheading:17563882-Intracellular Fluid, pubmed-meshheading:17563882-Muscarine, pubmed-meshheading:17563882-Oocytes, pubmed-meshheading:17563882-Patch-Clamp Techniques, pubmed-meshheading:17563882-Rats, pubmed-meshheading:17563882-Rats, Wistar, pubmed-meshheading:17563882-Receptor, Muscarinic M1, pubmed-meshheading:17563882-Receptor, Muscarinic M3, pubmed-meshheading:17563882-Receptor, Serotonin, 5-HT2C, pubmed-meshheading:17563882-Receptors, G-Protein-Coupled, pubmed-meshheading:17563882-Receptors, Neurokinin-1, pubmed-meshheading:17563882-Receptors, Neuropeptide, pubmed-meshheading:17563882-Xenopus laevis
pubmed:year
2007
pubmed:articleTitle
Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells.
pubmed:affiliation
Department of Anesthesiology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishiku, Kitakyushu, 807-8555, Japan.
pubmed:publicationType
Journal Article